133 related articles for article (PubMed ID: 36245986)
1. Mesoporous Silica Nanoparticles Loaded with Resveratrol Are Used for Targeted Breast Cancer Therapy.
Gu Y; Fei Z
J Oncol; 2022; 2022():8471331. PubMed ID: 36245986
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol-modified mesoporous silica nanoparticle for tumor-targeted therapy of gastric cancer.
Lin M; Yao W; Xiao Y; Dong Z; Huang W; Zhang F; Zhou X; Liang M
Bioengineered; 2021 Dec; 12(1):6343-6353. PubMed ID: 34506231
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery and apoptosis induction activity of peptide-transferrin targeted mesoporous silica encapsulated resveratrol in MCF-7 cells.
Li D; Song C; Zhang J; Zhao X
J Pharm Pharmacol; 2023 Jan; 75(1):49-56. PubMed ID: 36173891
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol-laden mesoporous silica nanoparticles regulate the autophagy and apoptosis via ROS-mediated p38-MAPK/HIF-1a /p53 signaling in hypertrophic scar fibroblasts.
Zuo J; Ma S
Heliyon; 2024 Feb; 10(4):e24985. PubMed ID: 38370262
[TBL] [Abstract][Full Text] [Related]
5. Layer-by-Layer Nanoparticles of Tamoxifen and Resveratrol for Dual Drug Delivery System and Potential Triple-Negative Breast Cancer Treatment.
Al-Jubori AA; Sulaiman GM; Tawfeeq AT; Mohammed HA; Khan RA; Mohammed SAA
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371789
[TBL] [Abstract][Full Text] [Related]
6. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
7. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
8. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
9. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis.
Li W; Guo Z; Zheng K; Ma K; Cui C; Wang L; Yuan Y; Tang Y
Int J Pharm; 2017 Dec; 534(1-2):71-80. PubMed ID: 28958879
[TBL] [Abstract][Full Text] [Related]
10. Nano-Gold Loaded with Resveratrol Enhance the Anti-Hepatoma Effect of Resveratrol
Zhang D; Zhang J; Zeng J; Li Z; Zuo H; Huang C; Zhao X
J Biomed Nanotechnol; 2019 Feb; 15(2):288-300. PubMed ID: 30596551
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol loaded polymeric micelles for theranostic targeting of breast cancer cells.
Gregoriou Y; Gregoriou G; Yilmaz V; Kapnisis K; Prokopi M; Anayiotos A; Strati K; Dietis N; Constantinou AI; Andreou C
Nanotheranostics; 2021; 5(1):113-124. PubMed ID: 33391978
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation and Enhanced Release of Resveratrol from Mesoporous Silica Nanoparticles for Melanoma Therapy.
Marinheiro D; Ferreira BJML; Oskoei P; Oliveira H; Daniel-da-Silva AL
Materials (Basel); 2021 Mar; 14(6):. PubMed ID: 33809119
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer.
Fan C; Kong F; Shetti D; Zhang B; Yang Y; Wei K
Biochem Biophys Res Commun; 2019 Nov; 519(2):378-384. PubMed ID: 31519327
[TBL] [Abstract][Full Text] [Related]
15. Colloidal mesoporous silica nanoparticles enhance the biological activity of resveratrol.
Summerlin N; Qu Z; Pujara N; Sheng Y; Jambhrunkar S; McGuckin M; Popat A
Colloids Surf B Biointerfaces; 2016 Aug; 144():1-7. PubMed ID: 27060664
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel.
He Y; Liang S; Long M; Xu H
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():12-17. PubMed ID: 28575958
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
[TBL] [Abstract][Full Text] [Related]
18. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
Song Y; Zhou B; Du X; Wang Y; Zhang J; Ai Y; Xia Z; Zhao G
Biomed Pharmacother; 2020 May; 125():109561. PubMed ID: 32106385
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol-Loaded TPGS-Resveratrol-Solid Lipid Nanoparticles for Multidrug-Resistant Therapy of Breast Cancer:
Wang W; Zhou M; Xu Y; Peng W; Zhang S; Li R; Zhang H; Zhang H; Cheng S; Wang Y; Wei X; Yue C; Yang Q; Chen C
Front Bioeng Biotechnol; 2021; 9():762489. PubMed ID: 34950642
[TBL] [Abstract][Full Text] [Related]
20. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.
Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X
Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
